All-Cause and Disease-specific Mortality and Morbidity in Patients With Congenital Hypothyroidism Treated Since the Neonatal Period: A National Population-based Study
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
CONTEXT: Little is known about the long-term health of patients treated for congenital hypothyroidism since the neonatal period. OBJECTIVE: To evaluate the causes of mortality and comorbidity in a population-based registry of young adult patients. DESIGN, SETTING, AND PARTICIPANTS: All 1772 eligible patients diagnosed during the first decade after the introduction of neonatal screening in France participated in the study. Follow-up data on vital status were available, in May 2010, for 99.5% of the patients. Completed questionnaires were obtained from 1202 of the selected patients. MAIN OUTCOME MEASURES: All-cause and cause-specific mortality and comorbidity. RESULTS: All-cause mortality in the congenital hypothyroidism (CH) patients was slightly higher than expected on the basis of year, age, and sex (standardized mortality ratio [SMR] 1.24, 95% CI: 0.81-1.82). SMRs for each category of underlying cause of death showed mortality due to diseases of the central nervous system (SMR 5.22, 95% CI: 1.68-12.17) and congenital malformations (SMR 3.15, 95% CI: 1.86-6.49) to be significantly higher than expected in the CH patients. The risk of developing an associated chronic disease in the 1202 patients who completed the questionnaire was twice that for the reference population (odds ratio 2.0 [1.32-3.03]). Neurologic or mental diseases and congenital malformations were the most frequent (odds ratios 2.54 [1.12-5.86], 4.18 [1.27-13.76], and 4.36 [1.24-15.34], respectively). Overall, mortality and morbidity were not affected by sex, disease severity, cause of CH, or adequacy of treatment. CONCLUSION: Prognosis has improved considerably, but a few patients diagnosed during the first 10 years of screening in France nonetheless displayed comorbidity and mortality due to various neurodevelopmental disorders and associated malformations. These results reveal a continuing need for improvements in care and studies to provide knowledge about the full spectrum of the disease and the mechanisms underlying these developmental abnormalities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Developmental delay in PSIS has not been studied extensively but has been described in some patients (26, 27).”
From Cognitive and Motor Outcome in Patients with Early-Detected Central Congenital Hypothyroidism Compared with Siblings (2021) · cites this paper as [27]
In the citing paper
“Finally, the prevalence of congenital malformations, particularly cardiac defects, including septal defects, and renal abnormalities (82) is higher in individuals with CH than in the general population, with differences in prevalence between studies (83–89);”
In the citing paper
“Moreover, in a large nationwide study, standardized mortality ratio in patients with CH was not increased for diseases of the circulatory system (87).”
In the citing paper
“In addition to an increased risk of congenital heart disease (86–88), neonates with untreated CH may have increased aortic intimal-media thickness (IMT), serum cholesterol levels (197), and impaired cardiac function (198,199) reversed by early LT4 treatment (200).”
Citations
Cites
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,592
Haddow, J. E., Palomaki, G. E., Allan, W. C., Williams, J. R., Knight, G. J., Gagnon, J., O'Heir, C. E., Mitchell, M. L., Hermos, R. J., Waisbren, S. E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410801 · Cited by 2,558
Molecular Aspects of Thyroid Hormone Actions
Cheng, S.-Y., Leonard, J. L., & Davis, P. J. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0007 · Cited by 1,384 · cited 5×
“None of the patients studied here displayed the biological profile typical of this rare disease, which is observed only in male patients, but there may be other, as yet unknown, molecular mechanisms facilitating TH access to the developing CNS (36, 37).”
BackgroundInfluentialSubclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality
Rodondi, N., den Elzen, W. P. J., Bauer, D. C., Cappola, A. R., Razvi, S., Walsh, J. P., Åsvold, B. O., Iervasi, G., Imaizumi, M., Collet, T.-H., et al. (2010) · JAMA · doi:10.1001/jama.2010.1361 · Cited by 1,216 · cited 1×
“Furthermore, in adult patients with acquired hypothyroidism, subclinical hypothyroidism has been associated with adverse outcomes, including an increase in the risk of coronary heart disease and mortality, particularly in patients with a thyroid-stimulating hormone (TSH) concentration of at least 10 mIU/L (8).”
BackgroundThe Disorders Induced by Iodine Deficiency
DELANGE, F. (1994) · Thyroid · doi:10.1089/thy.1994.4.107 · Cited by 638 · cited 1×
“Their synthesis is dependent on a normally developed thyroid gland, an adequate nutritional intake of iodine, and a series of biochemical steps (29).”
BackgroundClifton-Bligh, R. J., Wentworth, J. M., Heinz, P., Crisp, M. S., John, R., Lazarus, J. H., Ludgate, M., & Chatterjee, V. K. (1998) · Nature Genetics · doi:10.1038/1294 · Cited by 423
Castanet, M., Polak, M., Bonaïti-Pellié, C., Lyonnet, S., Czernichow, P., & Léger, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7501 · Cited by 240
Self-citationOlivieri, A., Stazi, M. A., Mastroiacovo, P., Fazzini, C., Medda, E., Spagnolo, A., De Angelis, S., Grandolfo, M. E., Taruscio, D., Cordeddu, V., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8235 · Cited by 224 · cited 1×
“expected, the frequency of extrathyroidal malformations and chromosomal abnormalities was higher in CH patients than in the reference population (4, 5, 7).”
BackgroundGrosse, S. D., & Van Vliet, G. (2011) · Archives of Disease in Childhood · doi:10.1136/adc.2010.190280 · Cited by 222 · cited 8×
“The prevention of neurologic deficits through the early initiation of treatment during the neonatal period is one of the chief justifications for the screening of newborns and has greatly modified disease prognosis (1, 2).”
BackgroundMethodInfluential
Cited by
Léger, J., Olivieri, A., Donaldson, M., Torresani, T., Krude, H., van Vliet, G., Polak, M., Butler, G., & on behalf of ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE, A. T. C. H. C. C. G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1891 · Cited by 569
Self-citationvan Trotsenburg, P., Stoupa, A., Léger, J., Rohrer, T., Peters, C., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0333 · Cited by 469
“Moreover, in a large nationwide study, standardized mortality ratio in patients with CH was not increased for diseases of the circulatory system (87).”
BackgroundSelf-citationLéger, J., Olivieri, A., Donaldson, M., Torresani, T., Krude, H., van Vliet, G., Polak, M., Butler, G., & on behalf of ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE, A. T. C. H. C. C. G. (2014) · Hormone Research in Paediatrics · doi:10.1159/000358198 · Cited by 208
Self-citationCongenital Hypothyroidism: Screening and Management
Rose, S. R., Wassner, A. J., Wintergerst, K. A., Jones, N. Y., Hopkin, R. J., Chuang, J., Smith, J. R., Abell, K. B., LAFRANCHI, S. H., Wintergerst, K. A., et al. (2022) · PEDIATRICS · doi:10.1542/peds.2022-060420 · Cited by 129
Lichtenberger-Geslin, L., Dos Santos, S., Hassani, Y., Ecosse, E., Van Den Abbeele, T., & Léger, J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1645 · Cited by 77
“However, in patients with severe CH, neonatal hyperbilirubinemia (22) or the significant association with neurodevelopmental disorders found in this population (40) might be involved.”
BackgroundSelf-citation
Metadata
- Authors
- Azar-Kolakez, A., Ecosse, E., Dos Santos, S., & Léger, J.
- Affiliations
- Assistance Publique – Hôpitaux de Paris (FR)
- Inserm (FR)
- Corresponding author
- Léger, Juliane
- ORCID
- Léger, Juliane
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-02
- Volume
- 98
- Issue
- 2
- Pages
- 785-793
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2025294316
- Cited by
- 27
- References
- 39
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 3 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 3 · 2014: 4 · 2013: 2
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- congenital hypothyroidism, long-term mortality, comorbidities, neurodevelopmental disorders, congenital malformations, central nervous system disorders, young adults, newborn screening, thyroid hormone replacement, standardized mortality ratio, disease severity, prognosis, France, United States comparison, United Kingdom comparison
- MeSH terms
- Adolescent, Adult, Cause of Death, Child, Child, Preschool, Congenital Hypothyroidism, Female, Follow-Up Studies, France, Humans, Infant, Infant, Newborn, Male, Prognosis, Surveys and Questionnaires, Neonatal Screening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: All-Cause and Disease-specific Mortality and Morbidity in Patients With Congenital Hypothyroidism Treated Since the Neonatal Period: A National Population-based Study. https://app.cochat.ai/papers/10.1210/jc.2012-2731
- The paper
- Azar-Kolakez, A., Ecosse, E., Dos Santos, S., & Léger, J. (2013). All-Cause and Disease-specific Mortality and Morbidity in Patients With Congenital Hypothyroidism Treated Since the Neonatal Period: A National Population-based Study. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2012-2731
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.